A Study of Durvalumab (MEDI4736) in Esophageal Cancer

NCT02639065 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shadia Jalal, MD

Collaborators